Shire Plc Ads (SHPG)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 303.36m
  • Volume: 0

Shire Plc Ads Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover 13.4
Op Mrgn 16.2%
ROCE 32.5%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 33.0%
PBT 297.1%
EPS 501.3%
DPS 15.0%

Shire Plc Ads Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 4,934.30 1,697.50 257.20¢ 54.9 0.7 +77% 19.93¢ 0.1%
31-Dec-14 6,022.10 3,338.90 559.60¢ 38.0 0.3 +118% 22.92¢ 0.1%
31-Dec-15 6,416.70 1,383.60 227.00¢ 90.3 n/a -59% 26.37¢ 0.1%
31-Dec-16 11,396.60 477.40 78.00¢ 218.4 n/a -66% 30.33¢ 0.2%
31-Dec-17 15,160.60 1,895.90 469.00¢ 33.1 0.1 +501% 34.88¢ 0.2%

Shire Plc Ads ShareCast News

No recent information was found.

Shire Plc Ads Top Newspaper Links

Margaret Hodge to grill PwC and Shire over tax a... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
US drugs company Shire relocates 500 jobs in maj... 21-Nov-2014 Express & Star

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Shire Plc Ads Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 303.36m

Trades for --2024

Time Volume / Share Price
0 @ $0.00

Shire Plc Ads Key Personnel

Chair Susan Kilsby
CEO Flemming Ornskov
CFO Thomas Dittrich

Top of Page